You have 9 free searches left this month | for more free features.

Condition

BRCA1/2 Mutation (1)

Glioblastoma (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Inovio Pharmaceuticals (1)

University of Pennsylvania (1)

Collaborator

Inovio Pharmaceuticals (1)

Intervention

ino-5401 (2)

ino-9012 (2)

cellectra 2000 (1)

cemiplimab (1)

radiation therapy (1)

temozolomide (1)

Study Documents

Intervention Type

drug (2)

biological (1)

device (1)

radiation (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

ino-5401

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

BRCA1/2 Mutation Trial in Philadelphia (INO-5401, INO-9012, Cellectra 2000)

Recruiting

BRCA1/2 Mutation

INO-5401
+2 more

Philadelphia, Pennsylvania

University of Pennsylvania

Dec 7, 2021

Glioblastoma Trial in United States (biological, radiation, drug)

Active, not recruiting

Glioblastoma

INO-5401
+4 more

Duarte, California
+20 more

Aug 8, 2022